Sign In
Buy VLON
$0.400
+0 (+0%)
At Close: Jul 20, 2023
Best Penny Stocks To Buy Now? 5 To Watch Before Next Week
02:30pm, Tuesday, 23'rd Nov 2021
Are these on your list of penny stocks right now? The post Best Penny Stocks To Buy Now?
Vallon Pharmaceuticals to Present at the Virtual Investor Roundtable Event
08:05am, Thursday, 11'th Nov 2021
- Live moderated video webcast discussion among members of management and ADHD and a buse e xpert, Stephen V. Faraone, Ph.D., on T hurs day, November 18 th at 3 :00 P M ET
Vallon Pharmaceuticals to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
08:35am, Wednesday, 10'th Nov 2021
- Live video webcast presentation on Monday, November 15 th at 8:30 am ET
Vallon Pharmaceuticals Provides Update on Recent Pipeline and Corporate Advancements
08:35am, Tuesday, 12'th Oct 2021
- L ead program, ADAIR , advancing toward completion of patient enrollment and treatment in ongoing SEAL study
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
08:05am, Tuesday, 14'th Sep 2021
- Inaugural a ppointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant abuse
Vallon Pharmaceuticals to Present at the Q3 Virtual Investor Summit
08:05am, Wednesday, 11'th Aug 2021
Live video webcast with David Baker, President and CEO of Vallon , on Wednesday , August 18 th 12 : 30 PM ET
Vallon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
08:05am, Tuesday, 10'th Aug 2021
- Company continues to drive enrollment in pivotal intranasal abuse study evaluating ADAIR toward completion before year-end 2021
Vallon Pharmaceuticals Announces Issuance of New European Patent Covering Method of Use and Composition of Matter for ADAIR
08:05am, Tuesday, 13'th Jul 2021
- Patent bolsters intellectual property protection as Company's partner, MEDICE, works to develop and potentially commercialize ADAIR in Europe and the UK
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
09:15am, Thursday, 13'th May 2021
- Company remains on track to report p ivotal data from lead program , ADAIR, in second half 2021
Vallon Pharmaceuticals Appoints Leanne Kelly as Chief Financial Officer
09:05am, Tuesday, 11'th May 2021
- Financial executive bringing over 20 years of experience in accounting, finance and management with a foundation established from big four accounting firm
Vallon Pharmaceuticals to Present at the Q2 Virtual Investor Summit
08:05am, Friday, 07'th May 2021
Live video webcast with David Baker, President and CEO of Vallon on Tuesday, May 18, 2021 at 4:15 PM ET
Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum
09:05am, Monday, 26'th Apr 2021
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry Panel on A pril 29 th at 10:30 AM ET
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
08:05am, Tuesday, 13'th Apr 2021
- Ongoing ADAIR SEAL study on target for pivotal data readout in second half of 2021 - Target NDA filing in Q2 2022 for a potential abuse-deterrent alternative to commercially available IR amphetamine
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning
07:55am, Tuesday, 13'th Apr 2021
Pre-market movers on Tuesday include ZOM stock, RIOT stock and AGC stock, following all sorts of big stock market news. The post Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on T
Vallon Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update
08:05am, Monday, 29'th Mar 2021
- Pivotal data from lead program, ADAIR, expected in second half 2021
